During the latest episode of Crypto Banter’s ‘The Sniper Trading Show’, the analyst delved into the market dynamics, specifically focusing on altcoin investments and long-term holdings. Emphasizing the significance of comparing performance against Bitcoin and Ethereum, the two dominant players in the market, he highlighted the need for investors to adjust settings to view currency performance relative to these cryptocurrencies.

While the past week has not seen many tokens outperforming Bitcoin due to temporary factors such as dominance retesting, some tokens have displayed promising performance compared to Bitcoin over the last month. With Bitcoin and Ethereum attracting attention and experiencing bullish trends, the spotlight is now on identifying tokens that have the potential to outperform. Tokens like Injective, Render, Blockstack, AVAX, Ethereum, and Sushi have shown signs of awakening and outperformance against Bitcoin.

The analyst noted that Ethereum has been a strong performer recently, with few tokens like dydx managing to outperform it. He believes that Ethereum will continue to outperform most altcoins in the near future, but when it makes a significant move, many altcoins will likely follow suit.

Drawing comparisons between Solana and Ethereum, the analyst pointed out that monitoring their performance against each other can indicate which is performing better. When the chart is green, Solana is outperforming, and when it’s red, Ethereum is ahead. For instance, swapping one Ethereum for Solana last September would have resulted in a gain of three Ethereum by now. While many focus on token prices, what truly matters is how they perform against Bitcoin and Ethereum.

Furthermore, the analyst highlighted the potential of platforms like Optimism in helping investors earn more Ethereum. He expressed a preference for charts displaying consistent patterns over time, like the one for Cosmos, suggesting that identifying changes in these patterns can lead to strategic moves. For example, selling one Ethereum to purchase Atom and later repurchasing Ethereum can contribute to asset growth.

He recommended gradually accumulating tokens like Injective and diving in when they start breaking through. With Theta currently in a favorable position, investors should keep in mind that in the last cycle, some tokens outperformed Ethereum by 1,300%. While Ethereum remains the primary focus at present, it’s essential to be prepared for the next phase when altcoins begin to surpass Ethereum.